Zhejiang Taimei Medical Technology Co., Ltd. (HKG:2576)

HKG:2576 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	253.01	319.3	517.92	666.74	679.31	1,478
Short-Term Investments	896.15	759.29	269.23	301.17	449.56	-
Trading Asset Securities	-	120.79	280.83	439.91	270.74	148.61
Cash & Short-Term Investments	1,149	1,199	1,068	1,408	1,400	1,626
Cash Growth	7.60%	12.30%	-24.14%	0.59%	-13.94%	142.90%
Accounts Receivable	185.58	186.63	167.68	171.46	129.24	63.2
Other Receivables	1.03	0.88	1.39	0.63	0.5	6.41
Receivables	186.62	187.5	169.07	172.09	129.74	69.61
Inventory	-	-	-	-	-	29.87
Restricted Cash	0.1	5.1	1.51	1.49	0.61	-
Other Current Assets	86.33	85.11	87.63	78.3	61.63	25.21
Total Current Assets	1,422	1,477	1,326	1,660	1,592	1,751
Property, Plant & Equipment	28.11	35.2	41.29	84.88	109.89	6.33
Goodwill	37.01	37.01	46.8	55.17	77.55	131.64
Other Intangible Assets	19.34	21.17	25.39	25.53	25.62	26.57
Long-Term Accounts Receivable	11.84	12.71	-	-	-	-
Long-Term Deferred Charges	-	-	-	-	-	4.27
Other Long-Term Assets	-	-	5	0.01	0.12	0.47
Total Assets	1,519	1,583	1,445	1,825	1,805	1,920
Accounts Payable	109.56	99.96	70.72	48.12	42.75	19.61
Accrued Expenses	52.7	66.6	119.59	164.38	132.06	73.85
Short-Term Debt	-	10	-	-	-	21.15
Current Portion of Leases	10.8	11.47	12.31	31.71	36.6	-
Current Income Taxes Payable	-	-	-	-	0.01	-
Current Unearned Revenue	69.7	86.7	137.39	136.53	127.5	88.35
Other Current Liabilities	8.65	17.85	17.87	10.68	10.71	9.48
Total Current Liabilities	251.41	292.59	357.87	391.43	349.62	212.44
Long-Term Leases	7.98	13.28	2.78	14.15	40.85	-
Long-Term Unearned Revenue	7.4	7.4	8.17	4.16	3.28	0.49
Long-Term Deferred Tax Liabilities	-	-	-	-	-	3.95
Other Long-Term Liabilities	35.32	35.35	33.74	32.23	-	3.39
Total Liabilities	302.1	348.62	402.56	441.97	393.75	220.27
Common Stock	563.78	563.78	538	538	538	538
Additional Paid-In Capital	1,389	1,389	1,130	1,130	1,130	1,467
Retained Earnings	-1,726	-1,703	-1,488	-1,142	-728.78	-305.27
Comprehensive Income & Other	919.52	908.53	799.15	783.99	472.17	-
Total Common Equity	1,146	1,158	978.33	1,310	1,411	1,700
Minority Interest	70.42	76.76	63.79	73.4	-	-
Shareholders' Equity	1,216	1,235	1,042	1,383	1,411	1,700
Total Liabilities & Equity	1,519	1,583	1,445	1,825	1,805	1,920
Total Debt	18.77	34.76	15.09	45.86	77.44	21.15
Net Cash (Debt)	1,130	1,165	1,053	1,362	1,322	1,605
Net Cash Growth	7.36%	10.61%	-22.69%	3.01%	-17.63%	141.67%
Net Cash Per Share	2.03	2.14	1.96	2.53	2.46	3.44
Filing Date Shares Outstanding	563.78	563.78	538	538	538	538
Total Common Shares Outstanding	563.78	563.78	538	538	538	538
Working Capital	1,171	1,185	968.32	1,268	1,242	1,539
Book Value Per Share	2.03	2.05	1.82	2.43	2.62	3.16
Tangible Book Value	1,090	1,100	906.14	1,229	1,308	1,542
Tangible Book Value Per Share	1.93	1.95	1.68	2.28	2.43	2.87
Machinery	24.74	23.69	27.01	25.12	21.58	12.04
Construction In Progress	-	-	0.04	0.71	9.98	-
Leasehold Improvements	51.42	51.37	46.72	43.51	17.33	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.